We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

93 hedge funds and large institutions have $414M invested in Twist Bioscience in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

11.46% more ownership

Funds ownership: 48.14% → 59.6% (+11%)

11% more funds holding

Funds holding: 84 → 93 (+9)

11% more capital invested

Capital invested by funds: $374M → $414M (+$39.7M)

Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
33
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$16.5M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$11.4M
3
BlackRock
BlackRock
New York
+$7.27M
4
Millennium Management
Millennium Management
New York
+$6.93M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$5.33M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.9M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$4.22M
4
CM
Castleark Management
Illinois
-$3.4M
5
Barclays
Barclays
United Kingdom
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$583K +$604K +25,831 +1,358%
TI
52
Trexquant Investment
Connecticut
$557K +$621K +26,547 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$540K – – –
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$539K +$14.7K +628 +3%
AGM
55
Alpine Global Management
New York
$527K +$588K +25,117 New
CCA
56
Conestoga Capital Advisors
Pennsylvania
$519K +$346K +14,800 +149%
Rafferty Asset Management
57
Rafferty Asset Management
New York
$488K -$503K -21,488 -48%
Barclays
58
Barclays
United Kingdom
$485K -$1.52M -64,999 -74%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$458K – – –
Swiss National Bank
60
Swiss National Bank
Switzerland
$458K +$23.4K +1,000 +5%
BM
61
Brandywine Managers
Delaware
$424K – – –
UBS Group
62
UBS Group
Switzerland
$378K -$959K -41,002 -70%
QSS
63
Quantitative Systematic Strategies
Florida
$352K +$393K +16,778 New
PL
64
Perpetual Ltd
Australia
$314K +$351K +15,000 New
AIG
65
American International Group
New York
$289K +$1.4K +60 +0.4%
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$281K -$9.85K -421 -3%
CSS
67
Cubist Systematic Strategies
Connecticut
$277K +$309K +13,194 New
Jane Street
68
Jane Street
New York
$260K +$289K +12,362 New
Man Group
69
Man Group
United Kingdom
$252K -$70.2K -3,000 -20%
Citigroup
70
Citigroup
New York
$237K -$332K -14,203 -56%
VF
71
Virtu Financial
New York
$222K +$247K +10,575 New
VOYA Investment Management
72
VOYA Investment Management
Georgia
$221K +$47.6K +2,033 +24%
MIM
73
MetLife Investment Management
New Jersey
$215K – – –
MWNA
74
Marshall Wace North America
New York
$215K +$240K +10,243 New
ProShare Advisors
75
ProShare Advisors
Maryland
$212K +$236K +10,091 New
1 2
3
4

TWST Hedge Fund Activity: Q4 2019 in Review

93 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2019, worth a combined $414M — up 11% from $374M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TWST positions and 7 closed out — a net gain of 15 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $16.5M. The largest seller was Emerald Advisers, cutting an estimated $5.33M.

  • 93 institutional investors held Twist Bioscience (TWST) as of Q4 2019, up from 84 in Q3 2019.
  • Funds reported $414M of Twist Bioscience stock for Q4 2019, up 11% quarter-over-quarter.
  • 22 funds opened new Twist Bioscience positions in Q4 2019 and 7 closed out, a net change of +15 holders.
  • The largest Twist Bioscience buyer in Q4 2019 was Capital World Investors, an estimated $16.5M added.
  • The largest Twist Bioscience seller in Q4 2019 was Emerald Advisers, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2019.